Identification of network-based differential gene expression signatures and their transcriptional factors to develop progressive blood biomarkers for Alzheimer’s disease

Author:

Jayaswamy Pavan K1,Gollapalli Pavan1,Alexander Lobo Manuel1,M Vijaykrishnaraj1,Patil Prakash1,Shetty Praveenkumar1

Affiliation:

1. KS. Hegde Medical Academy, Nitte (Deemed to be University)

Abstract

Abstract Background: Alzheimer's disease (AD) can go years without being undiagnosed due to a lack of biomarker identification with a growing incidence rate in the geriatric population. Identifying genes and their transcriptional factors and kinases that regulate the phosphorylation and pathogenesis of AD is a state-of-art approach to identifying novel diagnostic biomarkers. Methodology: Microarray dataset GSE140829 was retrieved from the GEO database to identify differentially expressed genes (DEGs) between AD and control samples. Furthermore, a protein interaction network was built using the String database, and DEGs were examined using Cytoscape based on high betweenness centrality (BC) and degree values. Additionally, the hub genes were identified via Cytohubba, and eight modules were then identified using molecular complex detection (MCODE). Results: Using a Venn diagram, we mined 1674 common DEGs from AD and control samples. The primary interaction data from the STRING consists of 1198 nodes and 1992 edges, which serve an extenuated network. Further, a core network was extracted from an extended network that consists of 676 nodes connected via 1955 edges and were analyzed based on high BC and Degree values. Based on the network topological analysis and network clustering, the hub genes were identified and further validated by coparing them with the backbone network. Compelling results from both the core network and backbone network HSP90AA1identified as a major blood biomarker, followed by HSPA5, CREBBP, UBC, GRB2, MAPK3, and TRAF6 are selected as the major biomarkers. Conclusion: This study shows the potential for predicting AD risk factors and identifies promising blood biomarkers for early AD diagnosis. Additionally, developing inhibitors for the identified transcriptional factors and kinases might improve future therapeutic applications.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3